Alnylam Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 94,245 | 0.1% | 237,005 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 104,716 | 0.1% | 229,641 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 68,994 | 0.0% | 211,581 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 54,404 | 0.0% | 201,481 | 3/31/2025 |
| 2024 Q4 | 4/23/2025 | 48,034 | 0.0% | 204,132 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 58,246 | 0.0% | 211,781 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 52,383 | 0.0% | 215,567 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 32,032 | 0.0% | 214,330 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 34,326 | 0.0% | 179,330 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 40,349 | 0.0% | 227,830 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 42,979 | 0.0% | 226,279 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 47,498 | 0.0% | 237,113 | 3/31/2023 |
| 2022 Q4 | 2/8/2023 | 64,375 | 0.1% | 270,883 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 53,995 | 0.0% | 269,760 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 34,502 | 0.0% | 236,555 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 40,105 | 0.0% | 245,603 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 52,515 | 0.0% | 309,675 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 60,223 | 0.0% | 318,959 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 53,855 | 0.0% | 317,692 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 45,187 | 0.0% | 320,047 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 43,376 | 0.0% | 333,740 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 38,490 | 0.0% | 264,351 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 37,882 | 0.0% | 255,768 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 24,034 | 0.0% | 220,800 | 3/31/2020 |
| 2019 Q4 | 1/27/2020 | 25,833 | 0.0% | 224,300 | 12/31/2019 |
| 2014 Q1 | 4/18/2014 | 7,490 | 0.0% | 119,911 | 3/31/2014 |
| 2013 Q4 | 2/13/2014 | 5,847 | 0.0% | 87,380 | 12/31/2013 |